The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...

The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...

"Boy Meets World" star Danielle Fishel said she is finished with radiation treatment for cancer and opened up about the side ...

As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...

Danielle Fishel is sharing an update about her health, saying she has completed “active cancer treatment” following her ...

Sharni Marks agreed to have a double mastectomy after learning she had a high breast cancer risk but the operation came too ...

Actress Rozlyn Khan is known for her good quality body of work and her vocal approach towards life. Shes never really afraid ...

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...

Tokyo: Daichi Sankyo has announced that DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the ...

Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...